GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acadia Pharmaceuticals Inc. (ACAD) [hlAlert]

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company is developing a portfolio consisting of its four product candidates, including
pimavanserin, which is in Phase III development for the treatment of Parkinson?s disease psychosis. In addition, the Company has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, Inc., and ACP-106 in IND-track development. The Company?s product candidates include Pimavanserin, AGN-XX/YY, AC-262271 and ACP-106. The Company maintains two wholly owned subsidiaries: ACADIA Pharmaceuticals AB based in Malmo, Sweden and ACADIA Pharmaceuticals A/S based in Denmark.
.
( Total: 14 Current Stock Recommendations )
Acadia Pharmaceuticals Inc.   (14)
Sell Hold 36% Buy 50%
Related companies
Opko Health Inc   (3)
Buy 100%
Talecris ...   (4)
Buy 100%
King ...   (13)
Sell Hold 62% Buy 31%
Mylan Laboratories, ...   (19)
Hold 32% Buy 68%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (23)
Hold 30% Buy 70%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 20% Buy 60%
Salix ...   (31)
Hold 32% Buy 68%
Show  

Date (ET)MemberRatingYTD
Gains
 
5/6/2008  
Sell
down  -6.60 %
9/1/2009  
Sell
down  -6.60 %
8/21/2007  
Buy
up  6.60 %
10/9/2007  
Buy
up  6.60 %
3/7/2008  
Buy
up  6.60 %
3/19/2013  
Buy
up  6.60 %
8/7/2013  
Buy
up  6.60 %
5/5/2009  
Buy
up  6.60 %
8/7/2013  
Buy
up  6.60 %
8/7/2013  
Hold
  
1/4/2013  
Hold
  
6/17/2008  
Hold
  
6/17/2008  
Hold
  
7/8/2008  
Hold
  

* As of 9/19/2014 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy